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KEYWORDS	
	 Two	 series	 of	 novel	 indole‐2‐carboxylic	 acid	 derivatives	 is	 reported.	 In	 the	 first	 series,	N‐
substituted	 derivatives	 (3a‐h)	 were	 synthesized	 via	 acylation	 of	 indole‐2‐carboxylic	 acid
followed	 by	 aldol	 condensation	 reaction.	 Whereas,	 in	 the	 second	 series,	 indole‐2‐
carboxamides	 (5a‐g)	 were	 synthesized	 through	 conversion	 of	 acid	 to	 its	 acid	 chloride
followed	by	coupling	of	substituted	anilines.	Structures	of	the	newly	synthesized	compounds
were	 confirmed	 by	 elemental	 analysis	 and	 spectral	 IR,	 1H	 NMR	 and	 mass	 data	 and	 were
screened	 for	 antioxidant	 activity.	 Among	 the	 first	 series,	 compound	 3g	 showed	 higher
antioxidant	 activity	 and	 whereas,	 in	 the	 second	 series	 compounds	 5b	 and	 5c	 exhibited
potential	 antioxidant	 activity.	 Compounds	 3g,	 5b	 and	 5c	 exhibited	 for	 its	 enhanced
antioxidant	activity.	
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1.	Introduction	
	
Evidences	suggests	 that	 free	radicals,	which	are	generated	
in	 many	 bioorganic	 redox	 processes,	 may	 induce	 oxidative	
damage	in	various	components	of	the	body	(e.g.,	lipids,	proteins	
and	 nucleic	 acids	 and	 may	 also	 be	 involved	 in	 the	 processes	
leading	 to	 the	 formations	 of	 mutations	 [1].	 The	 deleterious	
effects	of	an	imbalance	between	reactive	oxygen	species	(ROS)	
production	 and	 the	 available	 antioxidant	 defense	 capacity,	
termed	oxidative	stress,	as	well	as	its	role	in	the	aggravation	of	
a	plethora	of	pathological	conditions,	are	widely	documented	in	
the	 literature	 [2].	 Efforts	 to	 counteract	 the	damage	 caused	by	
these	 species	 are	 gaining	 acceptance	 as	 a	 basis	 for	 novel	
therapeutic	approaches	and	the	field	of	preventive	medicine	is	
experiencing	 an	 upsurge	 of	 interest	 in	 medically	 useful	
antioxidants	[3,4].	Antioxidants	play	a	significant	role	in	several	
important	 biological	 processes	 such	 as	 immunity,	 protection	
against	 tissue	 damage,	 reproduction	 and	 growth	 or	
development	 and	 can	 prevent	 cardiovascular	 disease,	 cancer,	
cataracts	 and	 various	 other	 ailments	 associated	 with	 ageing	
[5,6].	
Indole	 and	 its	 derivatives	 are	 found	 abundantly	 in	 nature	
and	 are	 known	 to	 exhibit	 potent	 physiological	 properties	 [7‐
10].	 Substituted	 indoles	 are	 capable	 of	 binding	 to	 many	
receptors	 with	 high	 affinity.	 Therefore,	 the	 synthesis	 and	
selective	 functionalization	 of	 indoles	 have	 been	 the	 focus	 of	
active	 research	 over	 the	 years	 [11‐17].	 Promoted	 from	 the	
above	findings	and	as	a	continuation	of	our	research	interest	in	
synthesis	and	biological	activities	of	novel	derivatives	of	some	
heterocyclic	 compounds	 [18‐20],	 the	 present	 study	 aimed	 to	
synthesis	 and	 to	 evaluate	 antioxidant	 potentials	 of	 novel	
indole‐2‐carboxylic	acid	analogues.	
	
	
2.	Experimental	
	
2.1.	Instrumentation	
	
All	 chemicals	 used	 were	 of	 laboratory	 grade	 (Qualigen,	
Merck).	The	melting	points	were	determined	by	open	capillary	
method	 on	 a	 Campbel	 electronic	 apparatus	 and	 are	
uncorrected.	 The	 IR	 spectra	 of	 synthesized	 compounds	 were	
recorded	 on	 a	 Shimadzu	 8400S	 FT‐IR	 in	 potassium	 bromide	
disks.	 The	 1H	 NMR	 was	 recorded	 in	 DMSO‐d6	 using	 a	 NMR	
Varian‐Mercury	400	MHz	spectrometer	and	chemical	shifts	are	
given	 in	 units	 as	 δ	 ppm,	 downfield	 from	 tetramethylsilane	
(TMS)	as	an	internal	standard.	Mass	spectra	were	obtained	on	
an	Electron	Impact	mass	spectrometer	using	Micromass	Q‐Tof‐
2	mass	spectrometers	at	70	eV	ionizing	beam	and	using	a	direct	
insertion	 probe.	 The	 progress	 of	 reactions	was	monitored	 by	
thin	 layer	 chromatography	 using	 chloroform‐methanol	 and	
hexane‐ethyl	 acetate	 as	 the	 solvent	 systems	 and	 spots	 were	
visualized	after	exposure	to	iodine	vapours	or	under	ultraviolet	
(UV)	light.	
	
2.2.	Synthesis	of	1‐acetyl‐1H‐indole‐2‐carboxylic	acid	(2)		
	
To	 a	 well	 stirred	 solution	 of	 1H‐indole‐2‐carboxylic	 acid					
(1	mM)	and	triethylamine	(1.2	mM)	in	15	mL	dichloromethane,	
acetyl	chloride	(1.3	mM)	 in	5	mL	was	added	drop	by	drop	for	
10	 min,	 then	 the	 reaction	 mixture	 is	 stirred	 at	 room	
temperature	 for	 about	 3	 hr.	 Progress	 of	 the	 reaction	 was	
monitored	 by	 thin	 layer	 chromatography	 (TLC)	 using	
hexane:ethylacetate	 (6:4)	 mixture	 as	 mobile	 phase.	 After	 the	
completion	of	reaction,	the	reaction	mass	was	quenched	in	ice	
cold	water	and	the	product	was	extracted	with	ethyl	acetate.		
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Figure	1.	Protocol	for	the	synthesis	of	indole‐2‐carboxylic	acid	derivatives,	(a)	N‐substituted	indole‐2‐carboxylic	acid	analogues,	(b)	indole‐2‐carboxamides.
	
	
The	organic	layer	was	washed	with	5%	NaHCO3	followed	by	
distilled	 water.	 Finally	 the	 organic	 layer	 was	 dried	 over	
anhydrous	Na2SO4.	 The	 brown	 solid	 product	was	 obtained	 by	
desolventation	through	rotary	evaporator.	
1‐acetyl‐1H‐indole‐2‐carboxylic	acid	(2):	Brown	solid.	Yield:	
87%.	 M.p.:	 175‐178	 oC.	 FT‐IR	 (KBr,	 cm‐1):	 1664	 (C=O),	 3347	
(OH),	2853‐2943	(Ar‐H).	1H	NMR	(400	MHz,	DMSO‐d6,	δ,	ppm):	
11.1	 (s,	 1H,	 COOH),	 6.92‐7.50	 (m,	 5H,	 Ar‐H),	 2.36	 (s,	 3H,	
COCH3).	MS	(EI,	m/z):	204.10	(M+1)+.	Anal.	calcd.	for	C11H9NO3	:	
C,	65.02;	H,	4.46;	N,	6.89;	O,	23.62%.	Found;	C,	65.05;	H,	4.43;	N,	
6.85;	O,	23.65%.	
	
2.3.	Synthesis	of	1H‐indole‐2‐carbonyl	chloride	(4)	
	
To	a	well	stirred	solution	of	1H‐indole‐2‐carboxylic	acid	(1	
mM)	in	15	mL	dry	tetrahydrofuran	(THF),	thionyl	chloride	(1.2	
mM)	 in	 3mL	 dry	 THF	was	 added	 drop	wise	 at	 0	 oC,	 then	 the	
reaction	mixture	is	stirred	at	room	temperature	for	about	3	h.	
Progress	 of	 the	 reaction	 was	 monitored	 by	 TLC	 using	
hexane:ethylacetate(6:4)	 mixture	 as	 mobile	 phase.	 After	 the	
completion	 of	 reaction,	 the	 product	 was	 extracted	 with	 ethyl	
acetate.	 The	 organic	 layer	 was	 washed	 with	 5%	 NaHCO3	
followed	by	distilled	water.	Finally	the	organic	layer	was	dried	
over	 anhydrous	 Na2SO4.	 The	 light	 brown	 solid	 product	 was	
obtained	by	desolventation	through	rotary	evaporator.	
Further,	coupling	of	substituted	aldehydes	and	substituted	
anilines	to	obtain	a	series	analogues	of	1H‐indole‐2‐carboxylic	
acid	 3a‐h	 and	 5a‐g	 in	 moderate	 good	 yield,	 which	 were	
identified	by	spectroscopic	techniques:	1H	NMR,	FT‐IR	and	MS‐
EI.	The	synthetic	strategies	of	 the	synthesized	compounds	are	
depicted	in	Figure	1	(Table	1).		
1H‐indole‐2‐carbonyl	chloride	 (4):	Light	brown	solid.	Yield:	
78%.	M.p.:	157‐160	oC.	FT‐IR	(KBr,	cm‐1):	1695	(C=O),	3338	(N‐
H),	 2873‐2927	 (Ar‐H).	 1H	NMR	 (400	MHz,	 DMSO‐d6,	 δ,	 ppm):	
11.91	 (s,	 1H,	 N‐H),	 6.91‐7.67	 (m,	 5H,	 Ar‐H).	 MS	 (EI,	 m/z):	
181.08	(M+1)+.	Anal.	 calcd.	 for	C9H6ClNO:	C,	60.19;	H,	3.37;	Cl,	
19.74;	N,	7.80;	O,	8.91%.	Found;	C,	60.17;	H,	3.39;	Cl,	19.78;	N,	
7.84;	O,	8.93.	
	
2.4.	General	procedure	for	the	synthesis	of	1‐acetyl‐1H‐
indole‐2‐carboxylic	acid	analogues	(3a‐h)	
	
To	 a	 solution	 of	 1‐acetyl‐1H‐indole‐2‐carboxylic	 acid	 (1	
mM)	in	ethanol	(10	mL)	substituted	benzaldehydes	were	added	
in	the	presence	of	10%	NaOH	at	room	temperature	(Figure	1).	
Progress	 of	 the	 reaction	 was	 monitored	 by	 TLC	 using	
chloroform:methanol	 (6:4)	mixture	as	mobile	phase.	After	 the	
completion	 of	 reaction,	 the	 product	 was	 extracted	 with	 ethyl	
acetate.	 The	 organic	 layer	 was	 washed	 with	 brine	 solution	
followed	by	distilled	water.	Finally	the	organic	layer	was	dried	
over	 anhydrous	Na2SO4.	 Further	 the	product	was	obtained	by	
desolventation	through	rotary	evaporator.	
	
Table	1.	Chemical	structures	of	the	synthesized	compounds.	
	
(Z)‐1‐(3‐phenylacryloyl)‐1H‐indole‐2‐carboxylic	 acid	 (3a):	
Brown	 semi	 solid.	 Yield:	 88%.	 FT‐IR	 (KBr,	 cm‐1):	 1664	 (C=O),	
3505	(OH),	2863‐2918	(Ar‐H).	1H	NMR	(400	MHz,	DMSO‐d6,	δ,	
ppm):	 11.3	 (s,	 1H,	 COOH),	 7.45‐7.50	 (m,	 5H,	 Ar‐H),	 6.91‐7.10	
Entry	 Entry	
3a	
	
5a	
	 	
3b	
	
5b	
	
3c	 5c	
	
3d	 5d	
	
3e	 5e	
	 	
3f	
	
5f	
	
3g	 5g	
3h	
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(m,	 5H,	 Ar‐H	 of	 R‐CHO),	 6.63	 (d,	 1H,	 CH=CH),	 6.59	 (d,	 1H,	
CH=CH).	 MS	 (EI,	 m/z):	 292.10	 (M+1)+.	 Anal.	 calcd.	 for	
C18H13NO3:	 C,	 74.22;	 H,	 4.50;	 N,	 4.81;	 O,	 16.48%.	 Found;	 C,	
74.25;	H,	4.52;	N,	4.84;	O,	16.45%.	
(Z)‐1‐(3‐(4‐chlorophenyl)acryloyl)‐1H‐indole‐2‐carboxylic	
acid	(3b):	White	semi	solid.	Yield:	81%.	FT‐IR	(KBr,	cm‐1):	1674	
(C=O),	 3445	 (OH),	 2853‐2948	 (Ar‐H).	 1H	 NMR	 (400	 MHz,	
DMSO‐d6,	δ,	ppm):	11.1	(s,	1H,	COOH),	7.21‐8.10	(m,	5H,	Ar‐H),	
7.22	(d,	4H,	Ar‐H	of	R‐CHO),	6.73	(d,	1H,	CH=CH),	6.68	(d,	1H,	
CH=CH).	 MS	 (EI,	 m/z):	 326.12	 (M+1)+.	 Anal.	 calcd.	 for	
C18H12ClNO3:	 C,	 66.37;	 H,	 3.71;	 Cl,	 10.88;	 N,	 4.30;	 O,	 14.73%.	
Found;	C,	66.39;	H,	3.71;	Cl,	10.85;	N,	4.27	O,	14.76%.	
(Z)‐1‐(3‐(4‐hydroxyphenyl)acryloyl)‐1H‐indole‐2‐carboxylic	
acid	(3c):	Light	brown	solid.	Yield:	87%.	M.p.:	105‐108	oC.	FT‐
IR	 (KBr,	 cm‐1):	 1624	 (C=O),	 3338	 (OH),	 2849‐2923	 (Ar‐H).	 1H	
NMR	(400	MHz,	DMSO‐d6,	δ,	ppm):	11.24	(s,	1H,	COOH),	7.21‐
7.86	 (m,	5H,	Ar‐H),	6.83‐7.10	 (d,	4H,	Ar‐H	of	R‐CHO),	7.22	 (d,	
1H,	 CH=CH),	 6.28	 (d,	 1H,	 CH=CH),	 5.34	 (s,	 1H,	 Phenolic	 ‐OH).	
MS	 (EI,	 m/z):	 308.12	 (M+1)+.	 Anal.	 calcd.	 for	 C18H13NO4:	 C,	
70.35;	H,	4.26;	N,	4.56;	O,	20.83%.	Found;	C,	70.37;	H,	4.24;	N,	
4.58;	O,	20.87%.	
(Z)‐1‐(3‐(4‐nitrophenyl)acryloyl)‐1H‐indole‐2‐carboxylic	
acid	 (3d):	 Brown	 solid.	 Yield:	 77%.	 M.p.:	 115‐118	 oC.	 FT‐IR	
(KBr,	cm‐1):	1664	(C=O),	3445	(OH),	2838‐2988	(Ar‐H).	1H	NMR	
(400	MHz,	DMSO‐d6,	δ,	ppm):	11.1	(s,	1H,	COOH),	7.45‐7.50	(m,	
5H,	 Ar‐H),	 6.86‐7.48	 (d,	 4H,	 Ar‐H	 of	 R‐CHO),	 6.73	 (d,	 1H,	
CH=CH),	 6.27	 (d,	 1H,	 CH=CH).	 MS	 (EI,	 m/z):	 337.20	 (M+1)+.	
Anal.	calcd.	for	C18H12N2O5:	C,	64.29;	H,	3.60;	N,	8.33;	O,	23.79%.	
Found;	C,	64.25;	H,	3.63;	N,	8.35;	O,	23.75%.	
(Z)‐1‐(3‐(4‐methoxyphenyl)acryloyl)‐1H‐indole‐2‐carboxylic	
acid	 (3e):	 Yellow	 solid.	 Yield:	 85%.	 M.p.:	 124‐127	 oC.	 FT‐IR	
(KBr,	cm‐1):	1683	(C=O),	3447	(OH),	2847‐2943	(Ar‐H).	1H	NMR	
(400	MHz,	DMSO‐d6,	δ,	ppm):	11.0	(s,	1H,	COOH),	7.45‐7.50	(m,	
5H,	 Ar‐H),	 6.91‐7.32	 (d,	 4H,	 Ar‐H	 of	 R‐CHO),	 7.11	 (d,	 1H,	
CH=CH),	6.93	(d,	1H,	CH=CH),	3.84	(s,	3H,	OCH3).	MS	(EI,	m/z):	
322.20	(M+1)+.	Anal.	calcd.	for	C19H15NO4:	C,	71.02;	H,	4.71;	N,	
4.36;	O,	19.92%.	Found;	C,	71.04;	H,	4.75;	N,	4.33;	O,	19.90%.	
(Z)‐1‐(3‐p‐tolylacryloyl)‐1H‐indole‐2‐carboxylic	 acid	 (3f):	
Brown	 semi	 solid.	 Yield:	 85%.	 FT‐IR	 (KBr,	 cm‐1):	 1663	 (C=O),	
3505	(OH),	2853‐2918	(Ar‐H).	1H	NMR	(400	MHz,	DMSO‐d6,	δ,	
ppm):	11.0	(s,	1H,	COOH),	7.45‐7.50	(m,	5H,	Ar‐H),	6.83‐7.10	(d,	
4H,	 Ar‐H	 R‐CHO),	 6.79	 (d,	 1H,	 CH=CH),	 6.63	 (d,	 1H,	 CH=CH),	
2.33	(s,	3H,	CH3).	MS	(EI,	m/z):	306.30	(M+1)+.	Anal.	calcd.	for	
C19H15NO3:	 C,	 74.74;	 H,	 4.95;	 N,	 4.59;	 O,	 15.72%.	 Found;	 C,	
74.72;	H,	4.96;	N,	4.59;	O,	15.71%.	
(Z)‐1‐(3‐(4‐hydroxy‐3‐methoxyphenyl)acryloyl)‐1H‐indole‐2‐
carboxylic	acid	(3g):	Yellow	solid.	Yield:	88%.	M.p.:	162‐165	oC.	
FT‐IR	 (KBr,	 cm‐1):	 1675	 (C=O),	3388	 (OH),	 2853‐2918	 (Ar‐H).	
1H	NMR	(400	MHz,	DMSO‐d6,	δ,	ppm):	11.2	(s,	1H,	COOH),	7.45‐
7.68	 (m,	5H,	Ar‐H),	7.10‐7.22	 (d,	3H,	Ar‐H	of	R‐CHO),	7.10	 (d,	
1H,	 CH=CH),	 6.64	 (d,	 1H,	 CH=CH),	 5.35	 (s,	 1H,	 phenolic	 OH),	
3.83	(s,	3H,	‐OCH3).	MS	(EI,	m/z):	338.20	(M+1)+.	Anal.	calcd.	for	
C19H15NO5:	 C,	 67.65;	 H,	 4.48;	 N,	 4.15;	 O,	 23.72%.	 Found;	 C,	
67.63;	H,	4.44;	N,	4.17;	O,	23.76%.	
(Z)‐1‐(3‐(3,4,5‐trimethoxyphenyl)acryloyl)‐1H‐indole‐2‐
carboxylic	acid	(3h):	White	solid.	Yield:	82%.	M.p.:	126‐129	oC.	
FT‐IR	 (KBr,	 cm‐1):	 1653	 (C=O),	3433	 (OH),	 2854‐2938	 (Ar‐H).	
1H	NMR	(400	MHz,	DMSO‐d6,	δ,	ppm):	11.0	(s,	1H,	COOH),	6.26‐
7.11	 (m,	 5H,	 Ar‐H),	 7.67	 (d,	 2H,	 Ar‐H	 of	 R‐CHO),	 7.42	 (d,	 1H,	
CH=CH),	7.46	(d,	1H,	CH=CH),	3.83	(m,	9H,	OCH3).	MS	(EI,	m/z):	
382.23	(M+1)+.	Anal.	calcd.	for	C21H19NO6:	C,	66.13;	H,	5.02;	N,	
3.67;	O,	25.17%.	Found;	C,	66.15;	H,	5.06;	N,	3.63;	O,	25.14%.	
	
2.5.	General	procedure	for	the	synthesis	of	1H‐indole‐2‐
carbonyl	chloride	analogues	(5a‐g)	
	
To	 a	 solution	 of	 1H‐indole‐2‐carbonyl	 chloride	 (1	mM)	 in	
dry	 THF	 (10	 mL)	 substituted	 anilines	 were	 added	 in	 the	
presence	 of	 TEA	 (3	 mL)	 under	 inert	 (N2)	 atmosphere.	 The	
reaction	mixture	was	 refluxed	 for	4	hr	 (Figure	1).	Progress	of	
the	reaction	was	monitored	by	TLC	using	chloroform:methanol	
(6:4)	mixture	as	mobile	phase.	After	the	completion	of	reaction,	
the	product	was	extracted	with	ethyl	acetate.	The	organic	layer	
was	 washed	 with	 5%	 NaHCO3	 solution	 followed	 by	 distilled	
water.	 Finally	 the	 organic	 layer	 was	 dried	 over	 anhydrous	
Na2SO4.	 Further	 the	 product	 was	 obtained	 by	 desolventation	
through	rotary	evaporator.	
N‐phenyl‐1H‐indole‐2‐carboxamide	(5a):	Yellow	solid.	Yield:	
82%.	M.p.:	115‐118	oC.	FT‐IR	(KBr,	cm‐1):	1656	(C=O),	3265	(N‐
H),	 2853‐2927	 (Ar‐H).	 1H	NMR	 (400	MHz,	 DMSO‐d6,	 δ,	 ppm):	
11.9	 (s,	 1H,	NH	of	 indole),	8.35	 (s,	1H,	NH	of	 amine),	7.1‐7.45	
(m,	 5H,	 Ar‐H),	 7.5‐7.75	 (d,	 4H,	 Ar‐H	 R‐NH2).	 MS	 (EI,	 m/z):	
237.28	(M+1)+.	Anal.	calcd.	 for	C15H12N2O:	C,	76.25;	H,	5.12;	N,	
11.86;	O,	6.77%.	Found;	C,	76.26;	H,	5.15;	N,	11.88;	O,	6.75%.	
N‐(4‐hydroxyphenyl)‐1H‐indole‐2‐carboxamide	 (5b):	 White	
solid.	 Yield:	 76%.	 M.p.:	 125‐128	 oC.	 FT‐IR	 (KBr,	 cm‐1):	 1695	
(C=O),	 3338	 (N‐H),	 2873‐2956	 (Ar‐H).	 1H	 NMR	 (400	 MHz,	
DMSO‐d6,	δ,	ppm):	11.7	(s,	1H,	NH	of	indole),	9.15	(s,	1H,	NH	of	
amine),	6.91‐7.54	(m,	5H,	Ar‐H),	7.45‐7.70	(d,	4H,	Ar‐H	R‐NH2),	
5.35	(s,	1H,	phenolic	OH).	MS	(EI,	m/z):	253.21	(M+1)+.	 	Anal.	
calcd.	 for	 C15H12N2O2:	 C,	 71.42;	 H,	 4.79;	 N,	 11.10;	 O,	 12.68%.	
Found;	C,	71.40;	H,	4.77;	N,	11.13;	O,	12.65%.	
N‐(2‐hydroxyphenyl)‐1H‐indole‐2‐carboxamide	 (5c):	 White	
solid.	 Yield:	 85%.	 M.p.:	 176‐179	 oC.	 FT‐IR	 (KBr,	 cm‐1):	 1695	
(C=O),	 3348	 (N‐H),	 2863‐2956	 (Ar‐H).	 1H	 NMR	 (400	 MHz,	
DMSO‐d6,	δ,	ppm):	11.9	(s,	1H,	NH	of	indole),	9.13	(s,	1H,	NH	of	
amine),	6.81‐7.59	(m,	5H,	Ar‐H),	7.44	‐7.99	(d,	4H,	Ar‐H	R‐NH2),	
5.3	 (s,	 1H,	 phenolic	 OH).	 MS	 (EI,	 m/z):	 253.18	 (M+1)+.	 Anal.	
calcd.	 for	 C15H12N2O2:	 C,	 71.42;	 H,	 4.79;	 N,	 11.10;	 O,	 12.68%.	
Found;	C,	71.41;	H,	4.77;	N,	11.14;	O,	12.66%.	
N‐(4‐methoxyphenyl)‐1H‐indole‐2‐carboxamide	 (5d):	Bright	
yellow	 solid.	 Yield:	 82%.	M.p.:	 111‐114	 oC.	 FT‐IR	 (KBr,	 cm‐1):	
1689	(C=O),	3317	(N‐H),	2873‐2933	(Ar‐H).	1H	NMR	(400	MHz,	
DMSO‐d6,	δ,	ppm):	11.62	(s,	1H,	NH	of	indole),	9.41	(s,	1H,	NH	of	
amine),	7.11‐7.57	(m,	5H,	Ar‐H),	7.51‐7.88	(d,	4H,	Ar‐H	R‐NH2),	
3.83	(s,	3H,	OCH3).	MS	(EI,	m/z):	267.32	(M+1)+.	Anal.	calcd.	for	
C16H14N2O2:	 C,	 72.16;	 H,	 5.30;	 N,	 10.52;	 O,	 12.02%.	 Found;	 C,	
72.17;	H,	5.27;	N,	10.55;	O,	12.06%.	
N‐(2‐methoxyphenyl)‐1H‐indole‐2‐carboxamide	 (5e):	White	
solid.	 Yield:	 72%.	 M.p.:	 185‐188	 oC.	 FT‐IR	 (KBr,	 cm‐1):	 1695	
(C=O,	 3378	 (N‐H),	 2823‐2986	 (Ar‐H).	 1H	 NMR	 (400	 MHz,	
DMSO‐d6,	δ,	ppm):	11.6	(s,	1H,	NH	of	indole),	9.43	(s,	1H,	NH	of	
amine),	6.86‐7.86	(m,	5H,	Ar‐H),	7.51‐7.90	(d,	4H,	Ar‐H	R‐NH2),	
3.83	(s,	3H,	OCH3).	MS	(EI,	m/z):	267.30	(M+1)+.	Anal.	calcd.	for	
C16H14N2O2:	 C,	 72.16;	 H,	 5.30;	 N,	 10.52;	 O,	 12.02%.	 Found;	 C,	
72.18;	H,	5.29;	N,	10.55;	O,	12.05%.	
N‐(4‐bromophenyl)‐1H‐indole‐2‐carboxamide	 (5f):	 White	
semi	solid.	Yield:	77%.	FT‐IR	(KBr,	cm‐1):	1775	(C=O),	3407	(N‐
H),	 2833‐2936	 (Ar‐H).	 1H	NMR	 (400	MHz,	 DMSO‐d6,	 δ,	 ppm):	
11.91	 (s,	1H,	NH	of	 indole),	 9.5	 (s,	1H,	NH	of	 amine),	7.1‐7.67	
(m,	 5H,	 Ar‐H),	 7.61‐8.11	 (d,	 4H,	 Ar‐H	 R‐NH2),	 MS	 (EI,	 m/z):	
316.36	 (M+1)+.	Anal.	 calcd.	 for	C15H11BrN2O:	C,	57.16;	H,	3.52;	
Br,	25.35;	N,	8.89;	O,	5.08%.	Found;	C,	57.16;	H,	3.54;	Br,	25.37;	
N,	8.85;	O,	5.05%.	
N‐(4‐nitrophenyl)‐1H‐indole‐2‐carboxamide	 (5g):	 White	
solid.	 Yield:	 70%.	 M.p.:	 106‐109	 oC.	 FT‐IR	 (KBr,	 cm‐1):	 1677	
(C=O),	 3438	 (N‐H),	 2873‐2956	 (Ar‐H).	 1H	 NMR	 (400	 MHz,	
DMSO‐d6,	δ,	ppm):	11.76	(s,	1H,	NH	of	indole),	9.1	(s,	1H,	NH	of	
amine),	7.33	‐7.71	(m,	5H,	Ar‐H),	7.64‐7.97	(d,	4H,	Ar‐H	R‐NH2).	
MS	 (EI,	 m/z):	 282.10	 (M+1)+.	 Anal.	 calcd.	 for	 C15H11N3O3:	 C,	
64.05;	H,	3.94;	N,	14.94;	O,	17.07%.	Found;	C,	64.09;	H,	3.92;	N,	
14.97;	O,	17.03%.	
	
2.6.	Antioxidant	activity	studies	
	
The	novel	synthesized	molecules	were	further	subjected	for	
the	 antioxidant	 evaluation	 by	 various	 in	 vitro	 assays	 like	2,2‐	
diphenyl‐1‐picrylhydrazyl	(DPPH)	radical	scavenging,	2,2‐azino	
bis(3‐ethylbenzothiazoline‐6‐sulfonic	 acid)	 (ABTS•+)	 radical	
cation	 decolorization	 assays,	 Ferric	 ion	 (Fe3+)	 reducing	
antioxidant	power	assay	(FRAP)	and	Cupric	ion	(Cu2+)	reducing	
ability	(CUPRAC	method).	
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2.6.1.	Free	radical	scavenging	activity	
	
The	newly	synthesized	compounds	were	screened	 for	 free	
radical	 scavenging	 activity	 by	 2,2‐diphenyl‐1‐picrylhydrazyl	
(DPPH)	 method	 [21].	 Compounds	 of	 different	 concentrations	
were	 prepared	 in	 distilled	 ethanol,	 1	 mL	 of	 each	 compound	
solutions	 (3a‐h)	 and	 (5a‐g)	 having	 different	 concentrations	
(10,	25,	50,	100,	200	and	500	µM)	were	taken	in	different	test	
tubes,	4	mL	of	0.1	mM	ethanol	solution	of	DPPH	was	added	and	
shaken	 vigorously.	 The	 test	 tubes	were	 then	 incubated	 in	 the	
dark	room	at	room	temperature	for	20	min.	A	DPPH	blank	was	
prepared	without	the	compound	and	ethanol	was	used	for	the	
baseline	 correction.	 Changes	 (decrease)	 in	 the	 absorbance	 at	
517	 nm	 were	 measured	 using	 a	 UV‐visible	 spectrometer	
(Shimadzu	 160	 A).	 The	 radical	 scavenging	 activities	 were	
expressed	 as	 the	 inhibition	 percentage	 and	 were	 calculated	
using	the	formula	(Equation	1):	
	
Radical	scavenging	activity	(%)	=	[(Ac‐As)/Ac)x100]	 (1)
	 	 	
where	Ac	is	absorbance	of	the	control	(without	compound)	and	
As	is	absorbance	of	the	compounds	3a‐h	and	5a‐g.	The	radical	
scavenging	 activity	 of	 BHA	 and	 ascorbic	 acid	 was	 also	
measured	and	compared	with	that	of	the	different	synthesized	
compounds.		
	
2.6.2.	ABTS•+	radical	scavenging	activity	
	
The	 synthesized	 indole‐2‐carboxylic	 acid	 analogues	 were	
subjected	 to	 2,2‐azino	 bis(3‐ethylbenzothiazoline‐6‐sulfonic	
acid)	 (ABTS•+)	 radical	 scavenging	 activity	 [22].	 The	 ABTS•+	
cation	was	 produced	 by	 the	 reaction	 between	 7	mM	ABTS	 in	
H2O	 and	2.45	mM	potassium	persulfate,	 stored	 in	 the	 dark	 at	
room	 temperature	 for	 12	 hr.	 Before	 the	 usage,	 the	 ABTS•+	
solution	 was	 diluted	 to	 get	 an	 absorbance	 of	 0.700±0.025	 at	
734	nm	with	phosphate	buffer	(0.1	M,	pH	=	7.4).	Then,	1	mL	of	
ABTS•+	 solution	was	 added	 to	 the	 compounds	3a‐h	 and	5a‐g	
solution	in	ethanol	at	different	concentrations	(1.5	mL,	10,	25,	
50,	 100,	 200,	 500	 µM/mL).	 After	 30	 min,	 the	 percentage	
inhibition	 at	 734	 nm	 was	 calculated	 for	 each	 concentration	
relative	to	a	blank	absorbance	(ethanol).		
The	scavenging	capability	of	ABTS•+	radical	was	calculated	
using	the	equation	2.	
	
ABTS•+	scavenging	effect	(%)	=	[(Ac‐As)	/	Ac]	x	100	 (2)
	 	
where,	 Acontrol	 is	 the	 initial	 concentration	 of	 the	 ABTS•+	 and	
Asample	 is	 the	 absorbance	 of	 the	 remaining	 concentration	 of	
ABTS•+	in	the	presence	of	the	compounds	3a‐h	and	5a‐g.	
	
2.6.3.	Ferric	ion	(Fe3+)	reducing	antioxidant	power	assay	
(FRAP)	
	
All	 the	 novel	 indole‐2‐carboxylic	 acid	 analogues	 were	
screened	 for	 ferric	 reducing	 antioxidant	 power	 [23].	 The	
compounds	3a‐h	 and	5a‐g	 having	 concentration	 (10	 μM/mL)	
were	mixed	with	phosphate	buffer	(2.5	mL,	0.2	M,	pH	=	6.6)	and	
potassium	 ferric	 cyanide	 (2.5	 mL,	 1%).	 The	 mixture	 was	
incubated	at	50	oC	for	20	min.	Later,	 the	reaction	mixture	was	
acidified	 with	 trichloroacetic	 acid	 (2.5	 mL,	 10%).	 After	 FeCl3	
(0.5	mL,	0.1%)	was	added	to	this	solution,	the	absorbance	was	
measured	at	700	nm.	The	increased	absorbance	of	the	reaction	
mixture	indicates	an	increased	reducing	power.	
	
2.6.4.	Cupric	ion	(Cu2+)	reducing	ability	(CUPRAC	method)		
	
All	the	synthesized	compounds	were	performed	cupric	ion	
reducing	 ability	 assay	 [24].	 Briefly,	 a	mixture	 of	 CuCl2	 (1	mL,	
0.01	M)	solution,	ethanolic	neocuproine	(Nc)	(1	mL,	7.5	x	10‐3	
M)	solution	and	ammonium	acetate	(1	mL,	1.0	M)	in	a	test	tube	
were	added	to	a	solution	of	compounds	3a‐h	and	5a‐g	 (1	mL,	
10	 µM)	 along	 with	 0.1	 mL	 distilled	 water.	 The	 mixture	 was	
incubated	 for	 30	min.	 Then	 the	 absorbance	was	measured	 at	
450	nm	against	reagent	blank.	
	
2.6.5.	Statistical	analysis	
	
Tests	 were	 carried	 out	 in	 triplicate	 for	 3‐5	 separate	
experiments.	The	amount	of	compound	needed	to	inhibit	DPPH	
free	 radicals	 and	 ABTS	 radicals	 concentration	 by	 50%,	 (IC50)	
was	graphically	estimated	using	a	linear	regression	algorithm.	
	
3.	Results	and	discussion	
	
3.1.	Chemistry	
	
To	 keep	 the	 electron‐withdrawing	 and	 electron‐donating	
character	 of	 the	 substituents	 in	 the	 molecule,	 we	 decided	 to	
study	 several	 indole‐2‐carboxylic	 acid	 analogues	 bearing	
electron	rich	and	deficient	substituents.	 In	 the	 first	 series,	 the	
key	intermediate	(2)	was	obtained	by	N‐acylation	using	acetyl	
chloride	in	the	presence	of	triethylamine	as	base.	Further,	aldol	
condensation	 of	 the	 key	 intermediate	 (2)	 with	 various	
substituted	aldehydes	 in	 the	presence	of	sodium	hydroxide	as	
base,	 afforded	 the	 corresponding	 N‐substituted	 indole‐2‐
carboxylic	acid	analogues	(3a‐h)	(Figure	1	(a)).	Further,	in	the	
second	 series	 indole‐2‐carboxamides	 (5a‐g)	 was	 obtained	 by	
conversion	of	acid	 to	acid	chlorides	 in	 the	presence	of	 thionyl	
chloride	 followed	 by	 coupling	 of	 substituted	 anilines	 through	
base	 condensation	 reaction	 in	 good	 yield	 (Figure	 1	 (b)).	 The	
newly	 synthesized	 compounds	 were	 purified	 by	 column	
chromatography	 using	 silica	 gel	 60‐120	 mesh	 and	
chloroform:methanol	 (60:40)	 as	 eluent.	 The	 synthesized	
compounds	 were	 characterized	 by	 various	 physico‐chemical	
and	 spectroscopic	 techniques	 like	 IR,	 1H	 NMR,	 mass	 and	
elemental	analysis.	The	absence	of	a	broad	absorption	band	at	
3300	cm‐1	corresponding	to	 ‐NH	absorption	and	a	sharp	band	
at	3347	cm‐1	corresponding	to	acid	group	in	IR	spectrum	of	key	
intermediate	(2)	and	the	absence	of	signal	at	11.91	ppm	in	1H	
NMR	confirms	the	acylation	to	‐NH	proton.	Similarly,	 in	the	IR	
spectra	 of	 key	 intermediate	 (4)	 exhibited	 the	 absence	 of	 a	
broad	absorption	band	at	3300	cm‐1	which	corresponds	to	acid	
group	 and	 the	 presence	 of	 a	 sharp	 absorption	 band	 at	 3338	
cm‐1	 for	 the	NH	absorptions	confirms	the	acid	 to	acid	chloride	
reaction	successfully.	
The	 IR	 spectra	 of	 all	 the	 substituted	 aldehyde	 analogues	
(3a‐h)	showed	the	absence	of	sharp	N‐H	band	ie.,	indole	(N‐H)	
band	at	around	3300‐3500	cm‐1	and	also	reveals	the	presence	
of	 aromatic	 peaks	 (Ar‐H)	 at	 the	 respective	 region	 2853‐2943	
cm‐1.	 Similarly,	 the	 IR	 spectra	 of	 all	 the	 substituted	 aniline	
analogues	 (5a‐g)	 showed	 a	 sharp	 N‐H	 band	 ie.,	 indole	 (N‐H)	
band	at	around	3304‐3438	cm‐1	and	also	reveals	the	presence	
of	 aromatic	 peaks	 (Ar‐H)	 at	 the	 respective	 region	 2823‐2986	
cm‐1.	 1H	 NMR	 spectra	 of	 all	 conjugated	 analogues	 (3a‐h)	
showed	 the	 absence	 of	 N‐H	 protons	 as	 singlet	 at	 11.91	 ppm.	
The	 signal	 due	 to	 acid	 ‐OH	 in	 all	 the	 analogues	 appeared	 as	
singlet	 at	 about	 11.0‐11.4	 ppm.	 In	 addition	 to	 acid	 ‐OH,	 the	
phenolic	‐OH	resonated	at	5.34	ppm	in	compound	3c	and	‐OCH3	
protons	 present	 in	 the	 compound	 5e	 resonated	 as	 singlet	 at	
3.83	ppm,	 other	 aromatic	 protons	were	 observed	 at	 expected	
regions	6.26‐8.10	ppm	for	(3a‐h)	and	6.81‐8.11	ppm	for	(5a‐g).		
	
3.2.	Antioxidant	activities	
	
3.2.1.	DPPH	radical	scavenging	activity	
	
The	 DPPH	 radical	 scavenging	 activity	 assay	 is	 a	 simple	
method	 for	 measuring	 the	 antioxidant	 ability	 to	 trap	 free	
radicals.	The	scavenging	effects	of	compounds	(3a‐h)	and	(5a‐
g)	 and	 two	 controls,	 BHA	 and	 ascorbic	 acid	 are	 evaluated	
(Table	 2).	 Compound	 3g	 containing	 hydroxy	 and	 methoxy	
group	 and	5b	 and	5c	 containing	 a	 hydroxy	moiety	 on	 phenyl	
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ring	 showed	 the	highest	 activity	 (IC50	 =	23	μM,	35	μM	and	45	
μM)	 among	 the	 synthesized	 analogues.	 Compound	 5e	
possessing	 methoxy	 group	 and	 3c	 having	 hydroxy	 group	 on	
phenyl	 moiety	 displayed	 promising	 activity	 (IC50	 =	 50	 μM	
and	65	μM).		
	
Table	2.	 IC50	 (Concentration	 required	 for	50%	 inhibition)	 values	 of	DPPH•	
and	ABTS•+	radical	scavenging	activities	of	the	compounds	(3a‐h)	and	(5a‐g)	
and	the	standard	antioxidant	compounds	such	as	BHA	and	Ascorbic	acid.		
Tested	compounds	 DPPH•		
Scavenging	activity (IC50)*
ABTS•+		
BHA	 12	 15	
Ascorbic	acid	 10	 12	
3a	 190	 140	
3b	 290	 265	
3c	 65	 52	
3d	 400	 200	
3e	 74	 86	
3f	 145	 123	
3g	 23	 20	
3h	 200	 315	
5a	 190	 175	
5b	 35	 28	
5c	 45	 40	
5d	 85	 68	
5e	 50	 62	
5f	 285	 375	
5g	 195	 164	
*	The	values	are	expressed	as	μM	concentration.	Lower	 IC50	values	 indicate	
higher	radical	scavenging	activity.	
	
3.2.2.	ABTS	radical	cation	scavenging	activity	
	
The	ABTS	assay	is	a	widely	used	method	for	measuring	the	
antioxidant	ability	 to	 trap	 free	radicals	 [22].	The	ABTS	radical	
cation	scavenging	capacity	of	the	synthesized	compounds	(3a‐
h)	 and	 (5a‐g)	 are	 screened	 Table	 2.	 Scaffold	 3g	 containing	
hydroxy	 and	 methoxy	 group	 and	 5b	 and	 5c	 containing	 a	
hydroxy	moiety	on	phenyl	ring	showed	good	ABTS	scavenging	
capacity	 (IC50	 =	 20	 μM,	 28	 μM	 and	 40	 μM).	 Whereas,	
compounds	3c,	5e	 and	5d	displayed	moderate	activity	 (IC50	=	
52	μM,	62	μM	and	68	μM).		
	
3.2.3.	Ferric	reducing	antioxidant	power	(FRAP)	
	
Ferric	 reducing	power	was	determined	using	 the	 iron(III)	
to	 iron(II)	 reduction	 assay.	 Since	 the	 antioxidant	 activity	 of	 a	
substance	is	usually	correlated	directly	to	its	reducing	capacity,	
the	 FRAP	 assay	 provides	 a	 reliable	 method	 to	 study	 the	
antioxidant	activity	of	various	compounds	[23].	Ferric	reducing	
ability	 of	 compounds	 (3a‐h)	 and	 (5a‐g)	 are	 studied	 Table	 3.	
Compounds	 3g,	 5b	 and	 5c	 showed	 the	 best	 reducing	 power	
(absorbance	 value	 =	 0.4144,	 0.3989	 and	 0.3791)	 among	 the	
synthesized	analogues	but	slightly	less	compared	to	that	of	the	
standards	 BHA	 and	 ascorbic	 acid.	 This	 may	 be	 due	 to	 the	
presence	of	electron	donating	capacity	of	hydroxy	and	methoxy	
groups	on	phenyl	ring.	While	 the	reducing	power	of	 the	other	
synthesized	 compounds	 3c,	 5d	 and	 3e	 showed	 moderate	
activity	and	compounds	3b,	5g,	3d	and	5f	containing	electron	
withdrawing	groups	like	‐Cl,	‐NO2	and	Br	showed	least	activity.	
The	 reducing	 power	 of	 all	 compounds	 and	 standards	 showed	
an	increase	by	rising	concentrations.		
	
3.3.4.	Cupric	ion	(Cu2+)	reducing	ability	(CUPRAC	method)	
	
The	CUPRAC	method	is	based	on	Cu(II)‐Cu(I)	reduction	by	
antioxidants	 in	 the	 presence	 of	 neocuproine.	 The	 copper	
reducing	ability	of	newly	synthesized	compounds	are	examined	
Table	 3.	 Among	 the	 synthesized	 analogues,	 compound	 3g,	
containing	 hydroxy	 and	 methoxy	 group	 and	 5b	 and	 5c	
containing	 a	 hydroxy	moiety	 on	 phenyl	 ring	 showed	 marked	
cupric	 ion	 reducing	ability	 (absorbance	value=	0.2980,	0.2132	
and	0.2104).	Whereas,	compounds	3c	and	5d	showed	average	
activity.		
	
Table	 3.	 Comparison	 of	 ferric	 ions	 (Fe3+)	 reducing	 ability	 by	 Fe3+‐Fe2+	
transformation	methods	and	Cu2+‐Cu+	reducing	ability	of	the	compounds	3a‐
h	 and	 5a‐g	 and	 the	 standard	 antioxidant	 compounds	 such	 as	 BHA	 and	
Ascorbic	acid	at	the	concentration	of	10	µM.	
Tested	compounds	 Fe
3+‐Fe2+
reducing	ability*	
Cu2+‐Cu+		
reducing	ability*	
BHA	 0.5462	 0.3534	
Ascorbic	acid 0.6362 0.4391	
3a 0.1577 0.0562	
3b 0.0971 0.0486	
3c 0.3556 0.2022	
3d 0.1137 0.0862	
3e 0.3410 0.1598	
3f	 0.1520	 0.1462	
3g	 0.4144	 0.2980	
3h	 0.2362	 0.1639	
5a 0.2163 0.1430	
5b		 0.3989	 0.2132	
5c 0.3791 0.2104	
5d 0.3218 0.1980	
5e 0.3164 0.1532	
5f 0.1116 0.1429	
5g 0.1034 0.1110	
*	The	 values	 are	 expressed	 as	 absorbance.	High	 absorbance	 indicates	 high	
reducing	power.	
	
4.	Conclusion		
	
In	 the	 present	 investigation,	 two	 series	 of	 novel	 indole‐2‐
carboxylic	 acid	 analogues	 (3a‐h)	 and	 (5a‐g)	 have	 been	
synthesized	 by	 a	 simple	 and	 convenient	 method.	 All	 the	
synthesized	 analogues	 were	 screened	 for	 their	 antioxidant	
activity	by	various	 in	vitro	assays.	Although	most	of	 the	above	
compounds	 exhibited	 more	 or	 less	 antioxidant	 activity	
compared	to	standards.	Compounds	3g,	5b	and	5c	exhibited	for	
its	 enhanced	 antioxidant	 activity.	 The	 antioxidant	 activities	 of	
these	 compounds	 are	 attributed	 to	 the	 presence	 of	 electron	
donating	 group	 such	 as	 ‐OH	 and	 ‐OCH3	 on	 the	phenyl	moiety.	
Along	with,	we	observed	the	presence	of	electron	withdrawing	
groups	 such	 as	 ‐Cl,	 ‐NO2	 and	 ‐Br	 on	 phenyl	 ring	 exhibited	
lowest	antioxidant	activity.	
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